Swan-Ganz CCOmbo V for Obtaining an Optimal Depth of Right Internal Jugular Venous Catheter

Insertion Depth of Central Venous Catheter Clinical Trial

Official title:

Swan-Ganz CCOmbo V for Obtaining an Optimal Depth of Right Internal Jugular Venous Catheter : A Prospective Observational Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03544151
• Other study ID #: 2018-012
• Status: Completed
• Start date: July 10, 2018
• Est. completion date: December 27, 2019

Study information

• Verified date: March 2020
• Source: RenJi Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators will perform a study to create formula for the optimal insertion depth of right internal jugular vein catheter.

Description:

Patients scheduled for cardiac surgery were studied.Determine the optimal insertion depth of right internal jugular vein catheter using Swan-Ganz Continuous Cardiac Output Thermodilutioon Cather (Swan-Ganz CCOmbo V).The investigators measure the distance between the insertion point and the junction between right atrium and superior vena cava using Swan-Ganz CCOmbo V.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 105
• Est. completion date: December 27, 2019
• Est. primary completion date: November 25, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult patient over 18 years of age undergoing mitral valve or/and tricuspid valve

• Surgery under general anesthesia, requiring Swan-Ganz Continuous Cardiac Output Thermodilutioon Cather (Swan-Ganz CCOmbo V) insertion through the right internal jugular vein.

Exclusion Criteria:

• A change in the mediastinal structure from previous neck surgery,thoracic surgery or cardiac surgery

• Extracardiac vascular anomaly

• Anatomical abnormality in neck and thorax

• Refusal to enrol

Related Conditions & MeSH terms

• Insertion Depth of Central Venous Catheter

Intervention

Device:
• Swan-Ganz Continuous Cardiac Output Thermodilutioon Cather (Swan-Ganz CCOmbo V)
Swan-Ganz CCOmbo V insertion

Locations

Country	Name	City	State
China	Diansan Su	Shanghai	Shanghai

Sponsors (1)

Lead Sponsor	Collaborator
RenJi Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The distance	The distance between the insertion point and the junction between right atrium and superior vena cava	After insertion of the Swan-Ganz Continuous Cardiac Output Thermodilutioon Cather (Swan-Ganz CCOmbo V) and during operation